NCT02956278View on ClinicalTrials.gov

The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Chronic GoutHyperuricemia
Interventions
DRUG

Allopurinol

OTHER

Placebo

lactose placebo pill

Trial Locations (1)

94040

Open Medicine Institute, Mountain View

Sponsors

Collaborators (1)

Open Medicine Institute
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Open Medicine Institute

UNKNOWN

lead

University of California, San Francisco

OTHER

NCT02956278 - The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics | Biotech Hunter | Biotech Hunter